Author details

Full Name

Rajen Mody

Affiliation

ORCID

Career Start Year

2001

Papers

108

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
38039965	A road map for the treatment of pediatric diffuse midline glioma.	Cancer Cell	2024
36622672	Evaluation of the Association Between Congenital Cytomegalovirus Infection and Pediatric Acute Lymphoblastic Leukemia.	JAMA Netw Open	2023
35838022	Internal evaluation of risk stratification tool using serial procalcitonin and clinical risk factors in pediatric febrile neutropenia: The non-interventional, single institution experience prior to clinical implementation.	Pediatr Hematol Oncol	2023
36206505	Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor.	Journal of Clinical Oncology	2023
36125251	Impact of socio-behavioral measures implemented during the SARS-CoV-2 pandemic on the outcomes of febrile neutropenia episodes in pediatric cancer patients: a single center quasi-experimental pre-post study.	Pediatr Hematol Oncol	2023
35605606	Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.	Neuro Oncol	2023
35465865	Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemia.	Infect Control Hosp Epidemiol	2023
38045418	Single-molecule systems for detection and monitoring of plasma circulating nucleosomes and oncoproteins in Diffuse Midline Glioma.	bioRxiv	2023
37851269	Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations.	Acta Neuropathol	2023
37584601	Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.	Cancer Discov	2023
36905190	Resolution of mandibular fibrous dysplasia following imatinib therapy in Noonan syndrome.		2023
36822669	KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children's Oncology Group.	J Immunother Cancer	2023
37012551	Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.	Nat Med	2023
35137228	Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma.	Neuro Oncol	2022
35644065	Homozygous ATM mutation due to germline uniparental isodisomy in patient with T acute lymphoblastic leukemia and hepatosplenic T-cell lymphoma.	Cancer Genet	2022
35735208	Adolescent and parent perspectives on genomic sequencing to inform cancer care.	Pediatr Blood Cancer	2022
35665495	Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.	Cancer	2022
36187937	BRCA1-associated RING domain-1 (BARD1) loss and GBP1 expression enhance sensitivity to DNA damage in Ewing sarcoma.	Cancer Res Commun	2022
33930008	Ongoing Response in a Multiply Relapsed Metastatic Posterior Fossa Ependymoma A After Vorinostat and Concomitant Irradiation.	J Pediatr Hematol Oncol	2022
35180323	Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.	Am J Hematol	2022
34709389	Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia.	JAMA Netw Open	2021
34003562	Unusual clinical behavior of a very late retinoblastoma relapse in a patient with a germline RB mutation.	Pediatr Blood Cancer	2021
33608379	Molecular insights into malignant progression of atypical choroid plexus papilloma.	Cold Spring Harb Mol Case Stud	2021
33550509	A novel ATXN1-DUX4 fusion expands the spectrum of 'CIC-rearranged sarcoma' of the CNS to include non-CIC alterations.	Acta Neuropathol	2021
34353848	Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia.	J Immunother Cancer	2021
31259827	Hepatosplenic Î±Î² T-Cell Lymphoma as Second Malignancy in Young Adult Patient With Previously Undiagnosed Ataxia-Telangiectasia.	Journal of Pediatric Hematology/Oncology	2020
32197665	Diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma.	Acta Neuropathol Commun	2020
32404749	Incidence and Sequelae of Liver Injury Among Children Treated for Solid Tumors: Analysis of a Large Single-Center Prospective Cohort.	Journal of Pediatric Gastroenterology and Nutrition	2020
32343642	Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group.	J Clin Oncol	2020
32338562	A phase I study of panobinostat in children with relapsed and refractory hematologic malignancies.	Pediatr Hematol Oncol	2020
32154134	Mutations predictive of hyperactive Ras signaling correlate with inferior survival across high-risk pediatric acute leukemia.	Transl Pediatr	2020
32482743	Vascular Access in Children With Blood Disorders or Cancer.	Pediatrics	2020
33087334	Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma.	Clin Cancer Res	2020
32976351	Accrual Trends for Children's Oncology Group Clinical Trials: A Single Center Experience.	Journal of Pediatric Hematology/Oncology	2020
32907837	The Emerging Role of Ras Pathway Signaling in Pediatric Cancer.	Cancer Res	2020
33015523	Clinical Sequencing of High-Grade Undifferentiated Sarcomas: A Case Series and Report of an Aggressive Primary Cardiac Tumor With Multiple Oncogenic Drivers.	JCO Precis Oncol	2020
32603316	Everolimus improves the efficacy of dasatinib in PDGFRÎ±-driven glioma.	J Clin Invest	2020
30709876	Refractory and metastatic infantile fibrosarcoma harboring <i>LMNA-NTRK1</i> fusion shows complete and durable response to crizotinib.	Cold Spring Harb Mol Case Stud	2019
31993359	KRAS mutant tenosynovial giant cell tumor in a pediatric patient: a case report.	Translational Pediatrics	2019
32832834	DICER1 Mutations in the Era of Expanding Integrative Clinical Sequencing in Pediatric Oncology.	JCO Precis Oncol	2019
35100716	BCOR Alterations in Pediatric and Young Adult Patients With Sarcomas and High-Grade Glial Malignancies: A Case Series.	JCO Precision Oncology	2019
30028819	Cryptic ETV6-ABL1 Fusion and MLL2 Truncation Revealed by Integrative Clinical Sequencing in Multiply Relapsed Acute Lymphoblastic Leukemia.	Journal of Pediatric Hematology/Oncology	2019
29554022	Clinical Implications of Real-time Integrative Sequencing in Management of Patients With Suspected Germline BAP1 Mutations.	J Pediatr Hematol Oncol	2019
30919136	Pediatric craniopharyngioma in association with familial adenomatous polyposis.	Fam Cancer	2019
31154346	Successful treatment of a <i>TSC2</i>-mutant glioblastoma with everolimus.	BMJ Case Rep	2019
31099289	A single-center multidisciplinary approach to managing the global Erwinia asparaginase shortage.	Leukemia and Lymphoma	2019
29235051	Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncology.	J Neurooncol	2018
32832831	Integration of Germline Pharmacogenetics Into a Tumor Sequencing Program.	JCO Precis Oncol	2018
32832832	Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain Tumors.	JCO Precis Oncol	2018
32832830	Exceptional Response to Cabozantinib in a Patient With Multiply Relapsed Wilms Tumor.	JCO Precis Oncol	2018